Skip to main content
Clinical Trials/IRCT201010094269N3
IRCT201010094269N3
Completed
未知

Comparison???? of efficacy of topical combination solution of salicylic acid 2% and erythromycin 4% with topical solution of erythromycin 4% alone in mild to moderate acne vulgaris treatment; double-blinded randomized clinical trial

Deputy of Tabriz University of Medical Sciences and Health Services0 sites50 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Mild to modrate acne vulgaris.
Sponsor
Deputy of Tabriz University of Medical Sciences and Health Services
Enrollment
50
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Deputy of Tabriz University of Medical Sciences and Health Services

Eligibility Criteria

Inclusion Criteria

  • Exclusion criteria:patients who are using topical or systemic steroids ; patients who are using contraceptive pills (anti\-androgen); patients who are used topical or oral anti\-acne medications, during the previous month, even include natural and UV light and Herbal and traditional acne treatments; if there are other face dermatosis and other systemic acne accelerator diseases such as Cushing's syndrome, PCO,adrenal hyperplasia, acquired and innate immun deficiency, steroid acne and acneiform lesions and ....; patient's dissatisfaction ;if there are more than 20 inflammatory lesions (papules and pustules) and three nodules or cysts on one side of the face ; patients with acne excoree ;age under 11 y/o andover 30 y/o ;if there is an inflammatory disease,except acne, on the face such as contact dermatitis, allergic or seborrheic dermatitis and...
  • patients with mild to moderate acne in age range 11\-30 years old ; patients who have maximum 20 inflammatory lesions (papules \&pustule) on one side of the face and have not more than three nodules or cysts on the same side of the face; lack of other face dermatosis such as contact dermatitis, allergic or seborrheic dermatitis and ...; having patient's satisfaction ; lack of other systemic acne accelerator diseases such as Cushing's syndrome, PCO, adrenal hyperplasia, acquired and innate immun deficiency, steroid acne and acneiform lesions and.... ; patients who are not used of oral or topical anti\-acne medications, during the previous month, even include natural and UV light, herbal and traditional acne treatments.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials